Jimmy Wei
Keine laufenden Positionen mehr
Karriereverlauf von Jimmy Wei
Ehemalige bekannte Positionen von Jimmy Wei
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
WI Harper Group, Inc.
 WI Harper Group, Inc. Investment ManagersFinance WI Harper Group, Inc. (WI Harper) is a venture capital firm founded in 1993 by Peter Liu. The firm is headquartered in San Francisco, California with additional offices in Beijing and Taipei. | Private-Equity-Analyst | - | 31.12.2007 |
| Private Equity Investor | - | 31.12.2007 | |
| Burrill China Group | Corporate Officer/Principal | - | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 24.03.2010 | - |
Ausbildung von Jimmy Wei
| University of Virginia | Masters Business Admin |
| North Carolina State University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| China | 3 |
Operativ
| Corporate Officer/Principal | 2 |
| Private Equity Analyst | 1 |
| Private Equity Investor | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
WI Harper Group, Inc.
WI Harper Group, Inc. Investment ManagersFinance WI Harper Group, Inc. (WI Harper) is a venture capital firm founded in 1993 by Peter Liu. The firm is headquartered in San Francisco, California with additional offices in Beijing and Taipei. | Finance |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Burrill China Group |
